SCHEMBL24654091

SCHEMBL24654091

CN1C(=O)C2(CC2(c2ccccc2)c2ccccc2)c2cc(Br)cc(Br)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PARK7 Q99497 1/20 0.34
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2A Q12879 2/20 0.32
BACE1 P56817 6/20 0.32
BACE2 Q9Y5Z0 2/20 0.32
REN P00797 1/20 0.32
APP P05067 1/20 0.32
CTSD P07339 1/20 0.32
PRMT5 O14744 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
PLIN1 O60240 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PLIN5 Q00G26 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29619626 1.00 HTR6 (0.38) HTR6MEN1KMT2APARK7MAPT
SCHEMBL29619586 0.80 MAPT (0.47) MEN1KMT2AMAPTLMNAGABRA1
SCHEMBL29619584 0.69 PTGDR2 (0.51) GABRA1GABRB2BACE1BACE2CTSD
SCHEMBL24654265 0.69 PTGDR2 (0.51) GABRA1GABRB2BACE1BACE2CTSD
SCHEMBL29619603 0.68 MAPT (0.48) MEN1KMT2AMAPTLMNABACE1
SCHEMBL29619619 0.68 ALDH1A1 (0.52) MEN1KMT2AMAPTLMNABACE1
SCHEMBL28515905 0.67 SLC27A2 (0.46) HTR6MEN1KMT2AMAPTLMNA
SCHEMBL29619573 0.67 SLC27A2 (0.46) HTR6MEN1KMT2AMAPTLMNA
SCHEMBL29619574 0.67 HCRTR1 (0.46) HTR6MEN1KMT2AMAPTALDH1A1
SCHEMBL29619636 0.66 TP53 (0.55) MEN1KMT2AMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315533-A1 METHOD FOR SYNTHESIZING 3-SPIRO THREE-MEMBERED RING INDOLINONE DERIVATIVE SOOCHOW UNIVERSITY (CN) 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315533-A1 METHOD FOR SYNTHESIZING 3-SPIRO THREE-MEMBERED RING INDOLINONE DERIVATIVE NES, NISCH, NCL HTR6 793/4885MEN1 751/4885KMT2A 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.